A multidisciplinary approach to treating a unique case of recurrent metastatic thymic carcinoma: case report
C Wang, D Erick Elkowitz, MJ Esposito… - … Advances in Rare …, 2023 - journals.sagepub.com
Thymic carcinoma (TC) is a rare and aggressive malignancy of the thymus associated with
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
[HTML][HTML] A multidisciplinary approach to treating a unique case of recurrent metastatic thymic carcinoma: case report
C Wang, DE Elkowitz, MJ Esposito… - … Advances in Rare …, 2023 - ncbi.nlm.nih.gov
Thymic carcinoma (TC) is a rare and aggressive malignancy of the thymus associated with
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
A multidisciplinary approach to treating a unique case of recurrent metastatic thymic carcinoma: case report
Therapeutic Advances in Rare Disease, 2023 - europepmc.org
Thymic carcinoma (TC) is a rare and aggressive malignancy of the thymus associated with
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
A multidisciplinary approach to treating a unique case of recurrent metastatic thymic carcinoma: case report
C Wang, DE Elkowitz, MJ Esposito… - … advances in rare …, 2023 - pubmed.ncbi.nlm.nih.gov
Thymic carcinoma (TC) is a rare and aggressive malignancy of the thymus associated with
less than 25% 5 years survivability. Our case report showcases the successful treatment of …
less than 25% 5 years survivability. Our case report showcases the successful treatment of …